pharmaceutical

The Food and Drug Administration (FDA) unveiled a new plan to boost the nation's domestic pharmaceutical supply.

President Donald Trump warned 17 major pharmaceutical companies on Thursday that they must lower prescription drug prices or face undisclosed punitive measures. The ultimatum follows his recent executive order aimed at bringing U.S. drug costs in line with prices in other developed nations.

President Trump sent letters to seventeen drug manufacturers, listing steps that must be taken to reduce prescription drug prices.

Pharmaceutical company AstraZeneca committed to investing $50 billion in the United States by 2030.

Biogen has announced a $2 billion investment to upgrade and expand its North Carolina operations, emphasizing automation and artificial intelligence in its manufacturing capabilities. The move solidifies its role as the largest biotechnology employer in the state and positions the company for future pharmaceutical innovation.

President Donald Trump signed an executive order on Monday directing drug prices to be cut by an estimated 59%.

President Donald Trump warned that tariffs are to be imposed on non-U.S.-based pharmaceuticals.

Drugmaker Eli Lilly announced plans to invest $27 billion in manufacturing plants in the United States.